In SLE patients, allogeneic UC-MSCs inhibit T cells response through IFN-γ/IDO axis (69), and induce more inducible Treg (iTreg) by generating anti-inflammatory cytokines, such as TGF-β1 (70, 71). This evidence concerns the gene TGFB1 and systemic lupus erythematosus.